Abstract
Ependymoma are rare malignant CNS tumors of the WHO grades I–III in children and adults with a tendency to spread within in the CSF. Several genetic subtypes with different clinical behaviors have been discovered. In localized tumors, gross total resection should be achieved. Radiotherapy is an effective adjuvant treatment and can also be used in in-operable cases. Efficacy of chemotherapy is very limited. Prognosis of metastatic and recurrent disease often remains poor.
This is a preview of subscription content, log in via an institution.
References
Abdel-Wahab M, Etuk B, Palermo J, Shirato H, Kresl J, Yapıcıer O, et al. Spinal cord gliomas: a multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys. 2006;64(4):1060–71. https://doi.org/10.1016/j.ijrobp.2005.09.038.
Agbahiwe HC, Wharam M, Batra S, Cohen K, Terezakis SA. Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013;85(2):421–7.
Aggarwal R, Yeung D, Kumar P, Muhlbauer M, Kun LE. Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma. Radiother Oncol. 1997;43(3):269–73. https://doi.org/10.1016/S0167-8140(97)01926-9.
Aguilera DG, Mazewski C, Schniederjan MJ, Leong T, Boydston W, MacDonald TJ. Neurofibromatosis-2 and spinal cord ependymomas: report of two cases and review of the literature. Childs Nerv Syst. 2011;27(5):757–64. https://doi.org/10.1007/s00381-010-1351-3.
Al-Halabi H, Montes JL, Atkinson J, Farmer J-P, Freeman CR. Adjuvant radiotherapy in the treatment of pediatric myxopapillary ependymomas. Pediatr Blood Cancer. 2010;55(4):639–43. https://doi.org/10.1002/pbc.22614.
Andreiuolo F, Puget S, Peyre M, Dantas-Barbosa C, Boddaert N, Philippe C, et al. Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. Neuro-Oncology. 2010;12(11):1126–34. https://doi.org/10.1093/neuonc/noq074.
Bagley CA, Wilson S, Kothbauer KF, Bookland MJ, Epstein F, Jallo GI. Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev. 2009;32(3):321–34. https://doi.org/10.1007/s10143-009-0190-8.
Bandopadhayay P, Silvera VM, Ciarlini PDSC, Malkin H, Bi WL, Bergthold G, et al. Myxopapillary ependymomas in children: imaging, treatment and outcomes. J Neuro-Oncol. 2016;126(1):165–74. https://doi.org/10.1007/s11060-015-1955-2.
Benesch M, Weber-Mzell D, Gerber NU, von Hoff K, Deinlein F, Krauss J, et al. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. J Neurosurg Pediatr. 2010;6(2):137–44. https://doi.org/10.3171/2010.5.PEDS09553.
Benesch M, Mynarek M, Witt H, Warmuth-Metz M, Pietsch T, Bison B, et al. Newly diagnosed metastatic intracranial ependymoma in children: frequency, molecular characteristics, treatment, and outcome in the prospective HIT series. Oncologist. 2019. https://doi.org/10.1634/theoncologist.2018-0489.
Bojaxhiu B, Ahlhelm F, Walser M, Placidi L, Kliebsch U, Mikroutsikos L, et al. Radiation necrosis and white matter lesions in pediatric patients with brain tumors treated with pencil beam scanning proton therapy. Int J Radiat Oncol Biol Phys. 2018;100(4):987–96. https://doi.org/10.1016/j.ijrobp.2017.11.037.
Boström A, Boström J, Hartmann W, Pietsch T, Feuss M, von Lehe M, Simon M. Treatment results in patients with intracranial ependymomas. Cen Eur Neurosurg. 2011;72(03):127–32. https://doi.org/10.1055/s-0031-1273745.
Bouffet E, Hawkins CE, Ballourah W, Taylor MD, Bartels UK, Schoenhoff N, et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys. 2012;83(5):1541–8. https://doi.org/10.1016/j.ijrobp.2011.10.039.
Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469–74. https://doi.org/10.1038/nature26000.
Cavalli FMG, Hübner J-M, Sharma T, Luu B, Sill M, Zapotocky M, et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathol. 2018;136(2):227–37. https://doi.org/10.1007/s00401-018-1888-x.
Chang CH, Housepian EM, Herbert C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93(6):1351–9. https://doi.org/10.1148/93.6.1351.
Combs SE, Thilmann C, Debus J, Schulz-Ertner D. Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT). BMC Cancer. 2006;6:222. https://doi.org/10.1186/1471-2407-6-222.
Conklin HM, Li C, Xiong X, Ogg RJ, Merchant TE. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol. 2008;26(24):3965–70. https://doi.org/10.1200/JCO.2007.15.9970.
Delgado-López PD, Corrales-García EM, Alonso-García E, García-Leal R, González-Rodrigálvarez R, Araus-Galdós E, Martín-Alonso J. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues. Clin Transl Oncol. 2019;8(4):323. https://doi.org/10.1007/s12094-019-02082-2.
Fassett DR, Pingree J, Kestle JRW. The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature. J Neurosurg. 2005;102(1 Suppl):59–64. https://doi.org/10.3171/ped.2005.102.1.0059.
Feldman WB, Clark AJ, Safaee M, Ames CP, Parsa AT. Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children. J Neurosurg Spine. 2013;19(4):471–6. https://doi.org/10.3171/2013.6.SPINE12927.
Frappaz D. An international clinical program for the diagnosis and treatment of children with ependymoma (SIOP-EP-II). NCT02265770. Centre Leon Berard. 2014. Online verfügbar unter https://clinicaltrials.gov/ct2/show/NCT02265770.
Garvin JH, Selch MT, Holmes E, Berger MS, Finlay JL, Flannery A, et al. Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children’s Cancer Group protocol 9942: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2012;59(7):1183–9. https://doi.org/10.1002/pbc.24274.
Gerstner E, Pajtler K. Ependymoma. Semin Neurol. 2018;38(01):104–11. https://doi.org/10.1055/s-0038-1636503.
Gilbert MR, Ruda R, Soffietti R. Ependymomas in adults. Curr Neurol Neurosci Rep. 2010;10(3):240–7. https://doi.org/10.1007/s11910-010-0109-3.
Goldwein JW. Effects of radiation therapy on skeletal growth in childhood. Clin Orthop Relat Res. 1991;262:101–7.
Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, et al. High failure rate in spinal ependymomas with long-term follow-up. Neuro-Oncology. 2005;7(3):254–9. https://doi.org/10.1215/S1152851704001231.
Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, et al. Chemotherapy for intracranial ependymoma in adults. BMC Cancer. 2016;16(1):ii1. https://doi.org/10.1186/s12885-016-2323-0.
Grill J, Deley L, Marie-Cécile, Gambarelli D, Raquin M-A, Couanet D, Pierre-Kahn A, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001;19(5):1288–96. https://doi.org/10.1200/JCO.2001.19.5.1288.
Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, et al. National Cancer Institute Workshop on Proton Therapy for Children: considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys. 2018;101(1):152–68. https://doi.org/10.1016/j.ijrobp.2018.01.013.
Hamilton KR, Lee SSI, Urquhart JC, Jonker BP. A systematic review of outcome in intramedullary ependymoma and astrocytoma. J Clin Neurosci. 2019;63:168–75. https://doi.org/10.1016/j.jocn.2019.02.001.
Hoffman LM, Plimpton SR, Foreman NK, Stence NV, Hankinson TC, Handler MH, et al. Fractionated stereotactic radiosurgery for recurrent ependymoma in children. J Neuro-Oncol. 2014;116(1):107–11. https://doi.org/10.1007/s11060-013-1259-3.
Hübner J-M, Kool M, Pfister SM, Pajtler KW. Epidemiology, molecular classification and WHO grading of ependymoma. J Neurosurg Sci. 2018;62(1):46–50.
Huynh M, Marcu LG, Giles E, Short M, Matthews D, Bezak E. Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system? A review of current evidence. Radiother Oncol. 2019;133:140–8. https://doi.org/10.1016/j.radonc.2019.01.009.
Indelicato DJ, Bradley JA, Rotondo RL, Nanda RH, Logie N, Sandler ES, et al. Outcomes following proton therapy for pediatric ependymoma. Acta oncologica (Stockholm, Sweden). 2018;57(5):644–8. https://doi.org/10.1080/0284186X.2017.1413248.
Jones B, Wilson P, Nagano A, Fenwick J, McKenna G. Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma. Br J Radiol. 2012;85(1018):e912–8. https://doi.org/10.1259/bjr/24498486.
Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 2001;92(12):3155–64.
Kano H, Su Y-H, Wu H-M, Simonova G, Liscak R, Cohen-Inbar O, et al. Stereotactic radiosurgery for intracranial ependymomas: an international multicenter study. Neurosurgery. 2019;84(1):227–34. https://doi.org/10.1093/neuros/nyy082.
Kilday J-P, Mitra B, Domerg C, Ward J, Andreiuolo F, Osteso-Ibanez T, et al. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children’s Cancer Leukaemia Group (CCLG), Societe Francaise d’Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP). Clin Cancer Res. 2012;18(7):2001–11. https://doi.org/10.1158/1078-0432.CCR-11-2489.
Klekamp J. Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results. J Neurosurg Spine. 2013;19(1):12–26. https://doi.org/10.3171/2013.3.SPINE121063.
Koshy M, Rich S, Merchant TE, Mahmood U, Regine WF, Kwok Y. Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J Neuro-Oncol. 2011;105(3):583–90. https://doi.org/10.1007/s11060-011-0624-3.
Kraetzig T, McLaughlin L, Bilsky MH, Laufer I. Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management. J Neurosurg Spine. 2018;28(2):201–8. https://doi.org/10.3171/2017.5.SPINE161164.
Laprie A, Hu Y, Alapetite C, Carrie C, Habrand J-L, Bolle S, et al. Paediatric brain tumours: a review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy. Cancer Radiother. 2015;19(8):775–89. https://doi.org/10.1016/j.canrad.2015.05.028.
Lo SS, Chang EL, Sloan AE. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in the management of intracranial ependymoma. Expert Rev Neurother. 2006;6(4):501–7. https://doi.org/10.1586/14737175.6.4.501.
Lobon MJ, Bautista F, Riet F, Dhermain F, Canale S, Dufour C, et al. Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey. Springerplus. 2016;5(1):879. https://doi.org/10.1186/s40064-016-2562-1.
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.
Macdonald SM, Laack NN, Terezakis S. Humbling advances in technology: protons, brainstem necrosis, and the self-driving car. Int J Radiat Oncol Biol Phys. 2017;97(2):216–9. https://doi.org/10.1016/j.ijrobp.2016.08.001.
Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stütz AM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 2014;506(7489):445–50. https://doi.org/10.1038/nature13108.
Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature. 2018;553(7686):101–5. https://doi.org/10.1038/nature25169.
Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, et al. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys. 2004;58(5):1336–45. https://doi.org/10.1016/j.ijrobp.2003.08.030.
Massimino M, Solero CL, Garrè ML, Biassoni V, Cama A, Genitori L, et al. Second-look surgery for ependymoma: the Italian experience. J Neurosurg Pediatr. 2011;8(3):246–50. https://doi.org/10.3171/2011.6.PEDS1142.
Massimino M, Miceli R, Giangaspero F, Boschetti L, Modena P, Antonelli M, et al. Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma. Neuro-Oncology. 2016;18(10):1451–60. https://doi.org/10.1093/neuonc/now108.
Merchant TE. Current clinical challenges in childhood ependymoma: a focused review. J Clin Oncol. 2017;35(21):2364–9. https://doi.org/10.1200/JCO.2017.73.1265.
Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol. 2004;22(15):3156–62. https://doi.org/10.1200/JCO.2004.11.142.
Merchant TE, Kiehna EN, Li C, Xiong X, Mulhern RK. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys. 2005;63(5):1546–54. https://doi.org/10.1016/j.ijrobp.2005.05.028.
Merchant TE, Boop FA, Kun LE, Sanford RA. A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys. 2008;71(1):87–97. https://doi.org/10.1016/j.ijrobp.2007.09.037.
Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009;10(3):258–66. https://doi.org/10.1016/S1470-2045(08)70342-5.
Merchant TE, Bendel AE, Sabin ND, Burger PC, Shaw DW, Chang E, et al. Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma. J Clin Oncol. 2019;37(12):974–83. https://doi.org/10.1200/JCO.18.01765.
Metellus P, Barrie M, Figarella-Branger D, Chinot O, Giorgi R, Gouvernet J, et al. Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain. 2007;130(5):1338–49. https://doi.org/10.1093/brain/awm046.
Murai T, Sato K, Iwabuchi M, Manabe Y, Ogino H, Iwata H, et al. Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy. Jpn J Radiol. 2016;34(3):211–8. https://doi.org/10.1007/s11604-015-0511-5.
Needle MN. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Unter Mitarbeit von Grass J. Goldwein JW. Hg. v. Cancer. 1997. Online verfügbar unter https://www.academia.edu/22236076/Adjuvant_chemotherapy_for_the_treatment_of_intracranial_ependymoma_of_childhood, zuletzt geprüft am 05.09.2019.
Nuño M, Yu JJ, Varshneya K, Alexander J, Mukherjee D, Black KL, Patil CG. Treatment and survival of supratentorial and posterior fossa ependymomas in adults. J Clin Neurosci. 2016;28:24–30. https://doi.org/10.1016/j.jocn.2015.11.014.
Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, et al. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro-Oncology. 2013;15(2):208–15. https://doi.org/10.1093/neuonc/nos286.
Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-Oncology. 2014;16(Suppl 4):iv1–63. https://doi.org/10.1093/neuonc/nou223.
Pajtler KW, Witt H, Sill M, Jones DTW, Hovestadt V, Kratochwil F, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728–43. https://doi.org/10.1016/j.ccell.2015.04.002.
Pencovich N, Bot G, Lidar Z, Korn A, Wostrack M, Meyer B, et al. Spinal ependymoma with regional metastasis at presentation. Acta Neurochir. 2014;156(6):1215–22. https://doi.org/10.1007/s00701-014-2048-2.
Perez CA, Wazer DE, Halperin EC, Brady LW, Hg. Perez and Brady’s principles and practice of radiation oncology. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 2013. Online verfügbar unter http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1473033
Peris-Bonet R, Martínez-García C, Lacour B, Petrovich S, Giner-Ripoll B, Navajas A, Steliarova-Foucher E. Childhood central nervous system tumours – incidence and survival in Europe (1978–1997): report from Automated Childhood Cancer Information System project. Eur J Cancer (Oxford, England: 1990). 2006;42(13):2064–80.
Pica A, Miller R, Villà S, Kadish SP, Anacak Y, Abusaris H, et al. The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys. 2009;74(4):1114–20. https://doi.org/10.1016/j.ijrobp.2008.09.034.
Pietsch T, Wohlers I, Goschzik T, Dreschmann V, Denkhaus D, Dörner E, et al. Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathway. Acta Neuropathol. 2014;127(4):609–11. https://doi.org/10.1007/s00401-014-1264-4.
Plotkin SR, O’Donnell CC, Curry WT, Bove CM, MacCollin M, Nunes FP. Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients. J Neurosur Spine. 2011;14(4):543–7.
Pusat S, Erbaş YC, Göçmen S, Kocaoğlu M, Erdoğan E. Natural course of myxopapillary ependymoma: unusual case report and review of literature. World Neurosurg. 2019;121:239–42. https://doi.org/10.1016/j.wneu.2018.10.028.
Rajagopal R, Foo JC, Jawin V, Qaddoumi I, Bouffet E. High-dose chemotherapy with autologous stem cell transplantation in infants and young children with ependymoma: a 10-year experience with the Head Start II protocol. Pediatr Transplant. 2019;23(4):e13421. https://doi.org/10.1111/petr.13421.
Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, et al. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. J Clin Oncol. 2016;34(21):2468–77. https://doi.org/10.1200/JCO.2015.65.7825.
Regnier E, Laprie A, Ducassou A, Bolle S, Supiot S, Muracciole X, et al. Re-irradiation of locally recurrent pediatric intracranial ependymoma: experience of the French society of children’s cancer. Radiother Oncol. 2019;132:1–7. https://doi.org/10.1016/j.radonc.2018.11.009.
Régnier E, Laprie A, Ducassou A, Bolle S, Supiot S, Muracciole X, et al. Re-irradiation of locally recurrent pediatric intracranial ependymoma: experience of the French society of children’s cancer. Radiother Oncol. 2019;132:1–7. https://doi.org/10.1016/j.radonc.2018.11.009.
Rudà R, Reifenberger G, Frappaz D, Pfister SM, Laprie A, Santarius T, et al. EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro-Oncology. 2018;20(4):445–56. https://doi.org/10.1093/neuonc/nox166.
Sato M, Gunther JR, Mahajan A, Jo E, Paulino AC, Adesina AM, et al. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer. 2017;123(13):2570–8. https://doi.org/10.1002/cncr.30623.
Smith AA. Maintenance chemotherapy or observation following induction chemotherapy and radiation therapy in treating patients with newly diagnosed ependymoma. NCT01096368. Children’s Oncology Group. 2010. Online verfügbar unter https://clinicaltrials.gov/ct2/show/NCT01096368.
Stauder MC, Laack N, Nadia, Ahmed KA, Link MJ, Schomberg PJ, Pollock BE. Stereotactic radiosurgery for patients with recurrent intracranial ependymomas. J Neuro-Oncol. 2012;108(3):507–12. https://doi.org/10.1007/s11060-012-0851-2.
Stephen JH, Sievert AJ, Madsen PJ, Judkins AR, Resnick AC, Storm PB, et al. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases. J Neurosurg Pediatr. 2012;9(6):646–53. https://doi.org/10.3171/2012.2.PEDS11285.
Strother DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L, et al. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro-Oncology. 2014;16(3):457–65. https://doi.org/10.1093/neuonc/not163.
Sun S, Wang J, Zhu M, Beejadhursing R, Gao P, Zhang X, et al. Clinical, radiological, and histological features and treatment outcomes of supratentorial extraventricular ependymoma: 14 cases from a single center. J Neurosurg. 2018;128(5):1396–402. https://doi.org/10.3171/2017.1.JNS161422.
Svoboda N, Bradac O, de Lacy P, Benes V. Intramedullary ependymoma: long-term outcome after surgery. Acta Neurochir. 2018;160(3):439–47. https://doi.org/10.1007/s00701-017-3430-7.
Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8(4):323–35.
Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand JL, Alapetite C, et al. Feasibility of dose escalation in patients with intracranial pediatric ependymoma. Front Oncol. 2019;9:531. https://doi.org/10.3389/fonc.2019.00531.
Thorp N, Gandola L. Management of ependymoma in children, adolescents and young adults. Clin Oncol (Royal College of Radiologists (Great Britain)). 2019;31(3):162–70. https://doi.org/10.1016/j.clon.2018.12.001.
Timmermann B, Kortmann R-D, Kühl J, Meisner C, Slavc I, Pietsch T, Bamberg M. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials hit 88/89 and hit 91. Int J Radiat Oncol Biol Phys. 2000;46(2):287–95. https://doi.org/10.1016/S0360-3016(99)00414-9.
Timmermann B, Kortmann R-D, Kühl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M. Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92. Radiother Oncol. 2005;77(3):278–85. https://doi.org/10.1016/j.radonc.2005.10.016.
Toescu SM, Aquilina K. Current and emerging methods of management of ependymoma. Curr Oncol Rep. 2019;21(9):445. https://doi.org/10.1007/s11912-019-0826-y.
Tsang DS, Burghen E, Klimo PJR, Boop FA, Ellison DW, Merchant TE. Outcomes after reirradiation for recurrent Pediatric intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2018;100(2):507–15. https://doi.org/10.1016/j.ijrobp.2017.10.002.
Tsang DS, Murray L, Ramaswamy V, Zapotocky M, Tabori U, Bartels U, et al. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma. Neuro-Oncology. 2019;21(4):547–57. https://doi.org/10.1093/neuonc/noy191.
Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Billups CA, Bowers DC, et al. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. Neuro-Oncology. 2019. https://doi.org/10.1093/neuonc/noz069.
Venkatramani R, Ji L, Lasky J, Haley K, Judkins A, Zhou S, et al. Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial. J Neuro-Oncol. 2013;113(2):285–91. https://doi.org/10.1007/s11060-013-1111-9.
Wang Y, Cai R, Wang R, Wang C, Chen C. Outcome predictors in the management of intramedullary classic ependymoma: an integrative survival analysis. Medicine. 2018;97(23):e10870. https://doi.org/10.1097/MD.0000000000010870.
Warmuth-Metz M, Bison B, Leykamm S. Neuroradiologic review in pediatric brain tumor studies. Klin Neuroradiol. 2009;19(4):263–73.
Weber DC, Wang Y, Miller R, Villa S, Zaucha R, Pica A, et al. Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro-Oncology. 2015;17(4):588–95. https://doi.org/10.1093/neuonc/nou293.
Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011;20(2):143–57. https://doi.org/10.1016/j.ccr.2011.07.007.
Wostrack M, Ringel F, Eicker SO, Jägersberg M, Schaller K, Kerschbaumer J, et al. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival. J Neurosurg Spine. 2018;28(6):654–62. https://doi.org/10.3171/2017.9.SPINE17494.
Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neurobiologia. 2016;18(7):902–13. https://doi.org/10.1093/neuonc/now016.
Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer. 2007;49(1):34–40. https://doi.org/10.1002/pbc.20935.
Zacharoulis S, Ji L, Pollack IF, Duffner P, Geyer R, Grill J, et al. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors. Pediatr Blood Cancer. 2008;50(2):231–5. https://doi.org/10.1002/pbc.21276.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Seidel, C., Dietzsch, S., Kortmann, RD., Schackert, G., Hau, P. (2020). Radiation Therapy in Ependymal Tumors. In: Wenz, F. (eds) Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-52619-5_4-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52619-5_4-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52619-5
Online ISBN: 978-3-319-52619-5
eBook Packages: Springer Reference MedicineReference Module Medicine